(Q40287051)

English

Synergy between an IGF-1R antibody and Raf/MEK/ERK and PI3K/Akt/mTOR pathway inhibitors in suppressing IGF-1R-mediated growth in hematopoietic cells.

scientific article published on 27 April 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16642049%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Synergy between an IGF-1R antibody and Raf/MEK/ERK and PI3K/Akt/mTOR pathway inhibitors in suppressing IGF-1R-mediated growth in hematopoietic cells (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16642049%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

based on heuristic

inferred from title

James A. McCubrey

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16642049%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Bertrand FE

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16642049%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Steelman LS

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16642049%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Chappell WH

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16642049%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Abrams SL

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16642049%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Shelton JG

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16642049%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

White ER

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16642049%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Ludwig DL

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16642049%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

27 April 2006

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16642049%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16642049%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16642049%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1254-1260

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16642049%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16642049%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404217

0 references

Clinical trials of antibody therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404217

21 January 2018

Anticancer antibodies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404217

21 January 2018

Simultaneous blockade of both the epidermal growth factor receptor and the insulin-like growth factor receptor signaling pathways in cancer cells with a fully human recombinant bispecific antibody.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404217

21 January 2018

Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404217

21 January 2018

Combination therapy enhances the inhibition of tumor growth with the fully human anti-type 1 insulin-like growth factor receptor monoclonal antibody CP-751,871.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404217

21 January 2018

In vivo effects of the human type I insulin-like growth factor receptor antibody A12 on androgen-dependent and androgen-independent xenograft human prostate tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404217

21 January 2018

A fully human recombinant IgG-like bispecific antibody to both the epidermal growth factor receptor and the insulin-like growth factor receptor for enhanced antitumor activity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404217

21 January 2018

The insulin-like growth factor system in regulation of normal and malignant hematopoiesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404217

21 January 2018

The insulin-like growth factor system and cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404217

21 January 2018

The IGF‐1 receptor in cancer biology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404217

21 January 2018

Conditional EGFR promotes cell cycle progression and prevention of apoptosis in the absence of autocrine cytokines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404217

21 January 2018

Effects of endogenous epidermal growth factor receptor signaling on DNA synthesis and ERK activation in a cytokine-dependent hematopoietic cell line

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404217

21 January 2018

Insulin-like growth factor-I receptor/human epidermal growth factor receptor 2 heterodimerization contributes to trastuzumab resistance of breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404217

21 January 2018

Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404217

21 January 2018

IGF1 and leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404217

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of a conditionally active v-ErbB and an EGF-R inhibitor on transformation of NIH-3T3 cells and abrogation of cytokine dependency of hematopoietic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404217

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin-like growth factor-1 receptor (IGF-1R) expression does not predict for resistance to trastuzumab-based treatment in patients with Her-2/neu overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404217

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2404217

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16642049%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Dimensions Publication ID

0 references

release_grsrv35airfgribunqoj4ktaoa

1 reference

https://api.fatcat.wiki/v0/release/grsrv35airfgribunqoj4ktaoa

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16642049%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40287051&oldid=1839615228"